YD Bio (YDESW) Current Assets (2024 - 2026)

YD Bio (YDESW) has reported Current Assets for 3 consecutive years, with $5.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets rose 300.29% year-over-year to $5.6 million in Q2 2026; TTM through Jun 2026 was $5.6 million, a 300.29% increase from a year earlier, with the FY2025 full-year figure at $9.7 million, up 178.85% from the prior year.
• Current Assets was $5.6 million for Q2 2026 at YD Bio, down from $9.7 million in the prior quarter.
• Over five years, Current Assets peaked at $9.7 million in Q4 2025 and troughed at $1.4 million in Q2 2025.
• A 3-year average of $5.0 million and a median of $4.5 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 178.85% in 2025 and soared 300.29% in 2026, its largest moves.
• Over 3 years, Current Assets stood at $3.5 million in 2024, then jumped by 178.85% to $9.7 million in 2025, then plunged by 42.18% to $5.6 million in 2026.
• The last three Current Assets figures came in at $5.6 million (Q2 2026), $9.7 million (Q4 2025), and $1.4 million (Q2 2025), per Business Quant data.